If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Product Launch » Public Relations
Download FREE Excerpt
49 Info Graphics
2 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Boehringer Ingelheim; Sprout Pharmaceuticals; Valeant
Best Practices, LLC conducted extensive secondary research of government and company information to review how Sprout Pharma used social media, active lobbying and policy levers to win approval for its controversial therapy, Addyi® (flibanserin) in female hypoactive sexual desire disorder (HSDD) category.
Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.